Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The triple agonist mechanism targets GLP-1, GIP, and glucagon receptors simultaneously, creating appetite suppression and metabolic enhancement that single-receptor medications cannot match
This treatment has an interesting background: Researchers created it as a modified form of Melanotan 2, which was initially studied for its tanning effects
We think of it as individuals with obesity have developed an appetite dysregulation
Sometimes, additional testing may be helpful
Presented for research literature review only Rabinovsky ED (2004)
US$ 27.00
US$ 24.48
US$ 27.89
US$ 27.34
US$ 25.79
